ISCT members discover that T-cells from recovered COVID-19 patients show promise to protect vulnerable patients from infection
Vancouver, Canada, October 30, 2020 - A team including ISCT member, Michael Keller, and ISCT Past President, Cath Bollard, have discovered that T-cells from recovered COVID-19 patients show promise to protect vulnerable patients from infection. Immunotherapy experts apply proven model to grow SARS-CoV-2-fighting T-cells from convalescent donors.
Read more from ScienceDaily »
View Original Article »
#News